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Summary
Background:  Few  studies  have  been  conducted  in  Jordan  related  to  health  care  asso-
ciated  bloodstream  infections  (HCABSIs).  This  study  aims  to  examine  epidemiology
of  HCABSIs  among  hospitalized  adult  patients  in  Jordan.
Methods:  A  cohort  study  (N  =  570;  445  conﬁrmed  HCABSIs,  125  uninfected  patients)
with  a  nested  1:1  matched  case—control  design  (n  =  125  in  each  group)  was  used
based  on  data  from  one  large  referral  hospital  in  Jordan  over  a  period  of  5  years.
HCABSI  cases  were  determined  based  on  conﬁrmed  positive  blood  culture  after  48  h
of  admission.  The  case—control  analyses  (n  =  250  per  group)  matched  on  gender,  age,
same  admission  month  and  unit.
Results:  The  overall  incidence  and  mortality  rates  were  8.1  and  5.8  per  1000
admissions,  respectively.  Four-variable  and  three-variable  multivariate  models  were
proposed  to  explain  the  risk  of  HCABSIs  in  the  matched  analyses  .The  four-
variable  model  consists  of  blood  product  (OR  =  24.5),  invasive  procedures  (OR  =  4.3),
renal  failure  (OR  =  9.2),  and  presence  of  other  infections  (OR  =  21.6).  The  three-
variable  model  consists  of  recipient  of  blood  product  (OR  =  19.7),  invasive  procedures
(OR  =  4.5),  and  renal  failure  (OR  =  9.4).
Conclusions:  This  study  is  a pioneer  study  that  examined  risk  factors,  the  associated
HCABSIs  in  Jordan.  Results  from  this  study  can  be  used  to  inﬂuence  infection  control
plans  in  Jordan.
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Background and signiﬁcance
Health  care-associated  infection  (HCAI),  particu-
larly health  care-associated  bloodstream  infections
(HCABSIs),  is  a  serious  and  complex  health  issue
worldwide  and  serious  patient  safety  and  qual-
ity of  care  concern  [1—3].  It  has  been  shown
that bloodstream  infections  (BSIs)  are  the  most
common  type  of  health  care  associated  infection
[4,5]. In  developing  countries,  such  as  Jordan,  this
problem becomes  more  complex  and  difﬁcult  to
manage because  of  limited  resources  and  poor  hand
hygiene compliance  among  health  care  providers
[6—8]. Prior  research  suggests  that  the  incidence
of HCABSIs  in  developing  countries  is  almost  ﬁve
times higher  than  the  international  standards
[9]. In  one  Jordanian  study,  the  BSIs  rates  were
higher than  the  90th  percentile  for  the  National
Nosocomial Infections  Surveillance  (NNIS)  infection
rates [10].
Based  on  the  most  recent  data  published  by  the
National  Center  for  Health  Statistics,  BSIs  are  the
tenth leading  cause  of  death  in  the  United  States
[11]. The  most  recent  published  estimates  in  the
U.S. suggested  that  approximately  500,000  cases
of HCABSIs  occurred  in  hospitalized  adult  patients
in 2003  [12].  This  study  estimated  that  the  patient
fatality  rate  was  20.6%,  which  translated  to  111,427
deaths  that  were  attributable  to  HCABSIs  in  2003
[12].
In addition  to  the  substantial  increase  in  mor-
bidity and  mortality,  HCABSIs  are  associated  with
signiﬁcantly  increased  mean  lengths  of  stay  (LOS)
and health  care  costs  [13,14].  Recent  U.S.  data  [15]
suggested that  in  2003  HCABSIs  potentially  cost  the
U.S. economy  approximately  $29  billion  (37.24  bil-
lion in  2010  $US).  This  study  [15]  also  suggested
that HCABSIs  result  in  approximately  8.5  extra  hos-
pitalization  days  for  affected  patients  compared  to
uninfected patients.
In  Jordan,  few  recent  studies  have  been  con-
ducted regarding  HCABSIs  [10,16,17]. Only  a few
studies have  examined  community-acquired  blood-
stream infections  in  adults  or  neonates  [18—21].
Therefore,  this  study  examines  the  epidemiology  of
HCABSIs among  hospitalized  adult  patients  in  Jorda-
nian hospitals.
Methods
Data source and study designThis  retrospective  study  used  a  cohort  study  design
that was  based  on  patient  admission  status  and
discharge  data  over  a  5-year  period  (5-31-2003  to
w
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-13-2008).  This  study  was  reviewed  and  approved
s a  minimal  risk  study  by  the  Institutional  Review
oard  for  the  Protection  of  Human  Subjects  (IRB)
rom the  participating  hospital  and  the  AL  AL-Bayt
niversity.
This  study  used  data  from  the  health  care  records
f patients  who  were  admitted  to  one  large  referral
ospital  in  the  north  of  Jordan  throughout  the  study
eriod. An  expert  nurse  performed  a  complete
hart review  for  each  of  the  study  cases.  Nested
ithin this  cohort  was  a 1:1  matched  case—control
tudy that  examined  the  HCABSI  risk  factors.
etting
his  large  teaching  hospital  has  a capacity  of 683
eds. The  acute  care  services  are  delivered  through
ifferent  types  of  intensive  care  units.  The  total
apacity  of  the  critical  care  unit  is  approximately
0 patients,  including  the  pediatric  intensive  care
nit.
ample
he  sample  was  composed  of  adult  patients  who
ere admitted  to  the  hospital  during  the  study
eriod. The  following  selection  criteria  were  used:
. adult  patient  (aged  18  years  and  older);
. a positive  blood  culture  after  48  h  of  admission;
and
. free of  bloodstream  infections  at  the  time  of
admission.
Adulthood  was  used  as  a selection  criterion
ased on  reports  suggesting  that  HCABSIs  among
hildren  and  infants  represent  a special  problem
n terms  of  incidence,  risk  factors,  and  other
elated issues  [22—25].  This  study  utilized  the  well-
ecognized  and  accepted  HCABSI  deﬁnition  that  has
een set  by  the  CDC  [26].  Therefore,  a laboratory-
onﬁrmed HCABSI  was  deﬁned  as  a clinical  infection
n which  at  least  one  microorganism  was  isolated
rom a blood  culture  that  was  drawn  at  least  48  h
fter a patient  admission,  with  no  evidence  of
nfection  at  the  time  of  admission  [27—29].  In  the
ohort  study,  the  infected  patients  were  compared
o adult  individuals  who  were  hospitalized  for  more
han 48  h,  admitted  to  the  same  unit  as  the  infected
atient,  and  free  of  BSI  at  the  time  of  admission  and
hroughout  their  hospitalizations.  The  LOS  in  the
omparison  group  was  equal  to  the  LOS  (±5%)  of  the
nfected patient  group  before  the  blood  cultures
ere drawn.
In the  nested  case—control  study,  125  patients
ho had  conﬁrmed  HCABSIs  and  who  met  the  selec-
ion were  matched  exactly  1:1  on  age  (except  for
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 pairs  for  whom  the  matching  was  based  on  a
ean  age  difference  of  ±7.9  years),  gender,  pri-
ary diagnosis  for  admission,  type  of  admission  unit
medical-surgical  or  critical  care),  and  admission
onth.
ata analysis procedures
escriptive  and  bivariate  analyses: The  analy-
es were  conducted  using  SPSS®-PC  Version  16.
requencies,  percentages,  means,  and  standard
eviations were  used  to  describe  the  sample.  Stata
version  10.0)  was  used  for  conditional  logistic
egression analyses.  Incidence  and  case-fatality
ates of  HCABSIs  for  each  year  were  manually
alculated using  the  SPSS-generated  frequencies
nd standard  formulas  [30].  In  the  current  study,
he incidence  and  mortality  rates  were  calculated
ased on  a  denominator  of  all  the  eligible  patients
fter applying  the  inclusion  criteria  (N  =  54,918
dult admissions).
The risk  factors  were  determined  based  on
ross-tabulations  and  a  risk  estimate  computation.
ge was  categorized  into  10-year  categories  and
ichotomized  using  a  cutoff  of  65  years  of  age;
his criterion  was  based  on  previous  similar  stud-
es [14,31].  The  risk  estimates  were  computed  for
ach age  category  and  for  the  dichotomized  65-year
ategory.  The  total  sample  (N  =  570)  was  used  for
omputing  the  risk  estimates  that  were  associated
ith the  admission  diagnosis  categories.  Standard
CD.9.CM  classiﬁcation  categories  [32]  were  used  to
lassify the  admission  diagnoses.  The  1:1  matched
ample  (N  =  250  in  each  group)  was  used  to  com-
ute the  risk  estimates  that  are  associated  with
omorbidities  and  risk  factors.
A conditional  logistic  regression  procedure  was
sed to  identify  the  predictors  of  HCABSIs  based
n the  matched  sample.  A  backward  elimination
i
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Figure  1  Incidence  and  mortality  rnian  study  405
rocedure  was  used  to  obtain  the  most  parsi-
onious model.  Variables  were  evaluated  at  the
% level  of  signiﬁcance  during  backward  elim-
nation. The  initial  variables  included  in  the
odel were:  hypertension,  malignancy,  diabetes
ellitus,  stroke,  coronary  artery  disease,  renal  fail-
re, chronic  obstructive  pulmonary  diseases,  ICU
dmission,  receiving  blood  products,  hemodialysis,
urgical procedure,  mechanical  ventilation,  central
enous catheters,  other  infections,  invasive  pro-
edures,  and  smoking.  Finally,  the  variables  were
ested for  multicollinearity,  but  no  signiﬁcant  evi-
ence for  multicollinearity  was  found.  The  variance
nﬂation  factors  (VIF)  factors  ranged  between  1.00
nd 1.07  (tolerance:  0.93—0.99).
esults
escription of the sample
uring  the  study  period,  there  were  a total  of
36,820 admissions.  After  applying  the  inclusion
riteria,  there  were  54,918  adult  admissions  avail-
ble for  analysis.  Over  the  study  period,  there  were
45 conﬁrmed  HCABSIs  in  the  hospital.  The  major-
ty of  positive  cultures  (55%)  were  taken  from  the
edical units,  and  19.4%  were  from  the  intensive
are units.  Of  the  445  total  infected  patients,  318
ied in  the  hospital;  therefore,  the  overall  crude
ase fatality  rate  was  71.5%.  The  overall  incidence
as 8.1  infections  per  1000  adult  admissions.  The
nnual incidence  ranged  from  5.3  infections  per
000 adult  admissions  in  2005  to  13.3  infections  per
000 adults  admissions  in  2007.  The  overall  mortal-
ty rate  was  5.8  deaths  per  1000  adult  admissions.
he mortality  rates  ranged  from  4.1  deaths  per  1000
dult admissions  in  2006  to  8.9  deaths  per  1000
dult admissions  in  2007  (Fig.  1).
ates  for  over  the  study  period.
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Table  1  Description  of  Demographic  Characteristics  of  All  Inpatient  Stays  and  Health  Care  Associated  Blood  Stream
Infected  Patients  and  Comparison  Group.
Characteristic  HCABSIs  (%)
N  =  445
Uninfected  (%)
N  =  125
Age
Ten-year  groups
18  — 29  52 (11.7)  8 (6.4)
30  — 39  45 (10.1)  15 (12.0)
40  — 49  52 (11.7)  20 (16.0)
50  —  59  79  (17.8)  26  (20.8)
60  —  69  91  (20.4)  28  (22.4)
≥  70  126  (28.3)  29  (23.2)
Dichotomous  grouping
More  than  65  years  176  (39.6)  46  (36.8)
Less  than  65  years  (reference)  269  (60.4)  80  (64.0)
Gender
Male  251  (56.4)  71  (56.8)
Female  (reference)  194  (43.6)  55  (44.0)
Admission  Diagnoses*
Infectious  and  parasitic  diseases 56  (12.6)  25  (20.0)
Neoplasms  and  blood  diseases  112  (25.3)  36  (28.8)
Endocrine,  nutritional  and  metabolic  diseases,  and  immunity  disorders  19  (4.3)  13  (10.4)
Diseases  of  the  nervous  system  and  sense  organs 43  (9.7)  7  (5.6)
Diseases  of  the  circulatory 41 (9.3)  4  (3.2)
Diseases  of  the  respiratory  systems 16 (3.6)  2 (1.6)
Diseases  of  the  digestive  system 35 (7.9)  13  (10.4)
Diseases  of  the  genitourinary  system 77 (17.4)  22 (17.6)
Injury,  poisoning,  other  diagnoses 44 (9.9)  3  (2.4)
Mean  age  (SD)** 56.4  (18.1)  56.0  (16.0)
Mean  total  length  of  stay  (SD)*** 27.7  (37.6)  8.3  (7.9)
Mean  LOS  after  blood  culture  (SD) 15.1  (27.6)  —
* Two HCABSIs cases with missing information.
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f** t (df = 586) = 0.17, p = 0.87.
*** t (df = 586) = 5.7, p < .01.
The  majority  of  infected  patients  were  male
(56.4%) and  aged  between  50  and  79  years  old
(58.2%).  The  mean  age  for  the  infected  patients
was 56.4  years  (SD  =  16.1),  compared  to  55.8  years
(SD =  16.1)  for  the  uninfected  group.  On  average,
the infected  patients  were  hospitalized  for  15.1
days (SD  =  27.6)  before  the  ﬁrst  blood  culture  was
drawn and  12.5  days  (SD  =  18.0)  after  the  blood
culture  was  drawn,  or  a  mean  total  of  27.7  days
(SD =  37.6)  for  the  hospital  stay.  The  mean  LOS
for the  uninfected  group  was  8.3  (SD  =  7.9)  days
(Table  1).
Pathogens
Of  the  total  conﬁrmed  infections,  speciﬁc  microor-
ganisms  were  not  identiﬁed  in  11.6%  (n  = 51)  of  the
positive cultures.  An  additional  4.9%  of  the  posi-
tive cultures  were  grouped  in  a  category  of  ‘other
speciﬁc causative  microorganism’  because  their
O
m
pndividual  frequency  was  less  than  0.5%.  The  most
revalent  speciﬁc  causative  agent  noted  in  the  cul-
ures was  Staphylococcus  aureus  (25.8%).  The  least
revalent agents  among  the  reported  causative
icroorganisms  were  Enterobacter  cloacae  and
cinetobacter  anitratus  (0.9%  each)  (Table  2).  Of
he total  conﬁrmed  positive  cultures,  13%  had  not
een tested  for  resistance  to  antibiotics.  Of  the
emaining  385  cultures,  87%  were  resistant  to  at
east one  type  of  antibiotic.  The  most  commonly
eported resistance  was  to  ampicillin  (19.2%),
ollowed by  ticarcillin/clavulanic  acid  resistance
15.1%).
esults of the matching procedure and  risk
actorsf  the  445  total  infected  patients,  125  (28.1%)  were
atched  with  a comparison  group  of  uninfected
atients. Although  the  matching  was  perfect  for
Health  care-associated  bloodstream  Infections:  A  Jorda
Table  2  Frequencies  and  Percentages  of  Pathogens
for  the  Infected  Group  (N  =  445).
Organism(s)  or  organism  group  Number  of
HCABSIs  (%)
Staphylococcus  aureus 115 (25.8)
Acinetobacter  calcoaceticus
baumannii
74 (16.6)
Escherichia  coli  51  (11.5)
Enterococcus  faecalis  37  (8.3)
Klebsiella  pneumoniae  26  (5.8)
Pseudomonas  aeruginosa  22  (4.9)
Streptococcus  oralis 11  (2.5)
Morganella  morganii 7 (1.6)
Salmonella  gallinarum  7  (1.6)
Streptococcus  pneumoniae  7  (1.6)
Pseudomonas  pseudomallei  7  (1.6)
Enterobacter  cloacae 4  (0.9)
Acinetobacter  anitratus 4 (0.9)
Other  speciﬁed  microorganisms 22 (4.9)
Unspeciﬁed  microorganisms 51 (11.6)
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It appears  that  both  the  clinical  data  in  the  cur-
rent study  and  the  administrative  data  in  the  USAender,  in  9  of  125  pairs,  the  patients  fell  into
djacent age  groups.  For  these  9  pairs,  the  differ-
nces  in  actual  age  ranged  between  2  and  12  years
M =  7.89,  SD  =  3.69).  Of  the  125  pairs,  56.8%  were
ale (n  = 142);  of  the  total  matched  pairs,  45%  were
ver 60  years  of  age,  and  of  125  pairs,  63.2%  (n  =  46)
ere matched  based  on  the  same  admission  unit.
Nearly 42%  of  the  infected  patients  had  at
east one  cardiovascular  disorder  (e.g.,  hyperten-
ion,  heart  failure,  or  coronary  artery  disease)
ompared to  32%  of  the  uninfected  group.  More
han one-fourth  of  the  infected  patients  had
ndergone at  least  one  type  of  invasive  proce-
ures (e.g.,  endoscopy,  bronchoscopy,  nasogastric
ntubation,  endotracheal  intubation,  colonoscopy,
ndoscopy, abdominal  paracentesis,  and/or  bone
arrow biopsy).  The  leading  comorbidity  that  was
ssociated  with  an  increased  risk  of  HCABSIs  was
‘renal  failure’’  (RR  =  2.9,  95%  CI:  1.6,  5.4).  Blood
roducts  recipients  experienced  the  greatest  risk
or HCABSIs  (RR  =  17.9,  95%  CI:  4.2,  77.2)  (Table  3).
Using a  conditional  logistic  regression  analy-
is, three  models  were  examined  (Table  4).  Model
 represented  the  Odds  Ratios  (OR),  which  are
djusted  for  matching  factors  but  not  for  other
isk factors.  The  four  retained  factors  were  ‘‘Blood
roducts’’,  ‘‘Invasive  Procedures’’,  ‘‘Renal  Fail-
re’’, and  ‘‘Other  Infections’’.  Model  2  adjusted
or matching  factors  and  all  other  factors  in  the  full
odel. In  Model  3,  we  dropped  ‘‘other  infections’’
s the  four-factor,  which  was  associated  with  a wide
5% conﬁdence  interval  (1.9—243.9).  The  pseudo  R2
or  Models  2  and  3  were  0.40  and  0.33,  respectively.
s
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iscussion
his  study  is  the  ﬁrst  to  provide  insight  into  the
pidemiology  of  HCABSIs  in  a  large  Jordanian  hospi-
al. The  study  estimated  that  the  overall  incidence
or HCABSIs  among  adult  hospitalized  patients  was
.1 infections  per  1000  admissions.  This  rate  was
imilar to  the  incidence  (8.5  infections  per  1000
dmissions)  reported  in  Saudi  Arabia  [33]  and  much
ower than  the  rate  reported  in  an  Egyptian  study
76 per  1000  ICU  admissions)  [34].  The  great  dis-
repancy  between  our  study  and  the  Egyptian  study
s consistent  with  the  fact  that  the  HCABSI  inci-
ence is  typically  higher  in  critical  care  units,
here the  study  in  Egypt  was  conducted.  Our  study
as comparable  with  the  Saudi  study  because  both
tudies included  all  hospitals  units,  and  both  stud-
es were  conducted  in  similar  medical  centers.  The
ncidence  reported  in  this  study  was  considerably
ower than  the  rate  of  26.1  per  1000  admissions
eported in  the  USA  from  a  large  population-based
tudy [12].  Although,  Al-Rawajfah  and  colleagues
sed  a  probability  sample,  the  HCABSI  sample  was
ased on  clinical  diagnosis  at  time  of  discharge
ather than  conﬁrmed  positive  cultures.  One  expla-
ation for  the  higher  incidence  in  the  American
tudy is  that  using  the  ICD-9-CM  coding  system
o locate  cases  inﬂated  the  estimate.  Another
lausible explanation  is  that  the  risk  is  genuinely
igher, although  some  unknown  proportion  of  inﬂa-
ion may  be  caused  by  clinical  suspicion,  which
ight not  be  supported  by  the  microbiological
ata.
In contrast,  our  study  ﬁndings  are  similar  to  the
CABSI infection  rate  of  6  cases  per  1000  admis-
ions reported  by  Wisplinghoff  and  colleagues  [13]
ased a  sample  from  49  U.S.  hospitals  and  a  total
f 24,179  conﬁrmed  infections.  Similar  to  our  study
nd the  Saudi  study,  Wisplinghoff  and  colleagues
13] only  used  laboratory-conﬁrmed  cases,  which
ay explain  the  consistency  of  these  ﬁndings.
Moreover,  the  overall  in-hospital  mortality  rate
hat was  reported  in  this  study  was  5.8  deaths
er 1000  admissions.  This  ﬁgure  was  much  lower
han the  ﬁgures  reported  in  other  Middle  Eastern
ountries, such  as  Egypt  (29.1  per  1000  ICU  admis-
ions) [34].  The  high  mortality  rate  in  the  Egyptian
tudy was  expected  because  the  study  was  set  in
ritical care  units.  In  contrast,  the  mortality  rate  in
his study  (5.8  deaths  per  1000  adults)  was  close  to
he rate  of  4.4  deaths  per  1000  admissions  reported
n the  USA  by  a  large  population-based  study  [12].tudy were  sensitive  in  capturing  deaths.  Unfortu-
ately,  Wisplinghoff  and  colleagues  [13],  who  used
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Table  3  Matched  Case-Control  Study  and  Estimates  of  the  Relative  Risk  and  their  95%  Conﬁdence  Intervals.
Characteristic  HCABSIs
Cases  (%)
N  =  125
Matched  Controls
(%)
N  =  125
Estimated
Relative  Risk
95%  CI
Comorbidities
Cerebrovascular  accident  (CVA)
Yes 13 (10.4)  6  (4.8)  2.30  (0.85,  6.27)
No 112 (89.6)  119 (95.2)  — —
Cardiovascular
Yes 53 (42.4)  40 (32)  1.56  (0.93,  2.62)
No  72  (57.6)  85  (68.0)  —  —
Diabetes  Mellitus*
Yes  43  (34.7)  37  (29.6)  1.26  (0.74,  2.15)
No  81  (65.3)  88  (70.4)  —  —
Cancer
Yes 35 (28.0)  36 (28.8)  0.96  (0.55,  1.67)
No 90 (72.0)  89 (71.2)  — —
Renal  Failure
Yes  41  (32.8)  18  (14.4)  2.90  (1.56,  5.41)
No  84  (67.2)  107  (85.6)  —  —
Other  Risk  Factors
Invasive  Procedures
Yes  32  (25.6)  10  (8.0)  3.96  (1.85,  8.47)
No  93  (74.4)  115  (92.0)  —  —
Central  Venous  Line
Yes  11  (8.80)  0  (0.0)  n/a  n/a
No  114  (91.2)  125  (100.0)  —  —
Receipt  of  Blood  Product*
Yes  28  (22.6)  2  (1.6)  17.94  (4.17,  77.18)
No  96  (77.4)  123  (98.4)  —  —
Other  Infections
Yes 46 (36.8)  28 (22.4)  2.02  (1.16,  3.52)
No  79  (63.2)  97  (77.6)  —  —
* One HCABSIs case with missing information.
** For  the  HCABSIs  versus  uninfected  mean  comparison,  p  <  .05.
n/a  means  not  available  because  at  least  one  cell  is  empty.
Table  4  Matched  Case-control  Study  of  Risk  Factors  for  Health  Care  Associated  Bloodstream  Infections,  n =  125
per  group.
Model  1a Model  2b Model  3c
Independent  Risk  Factor  Conditional
Odds  Ratio
95% CI  Conditional
Odds  Ratio
95% CI  Conditional
Odds  Ratio
95%  CI
Blood  Products  17.9  4.2—77.2  24.5  4.2—143.2  19.7  3.7—103.80
Invasive  Procedures  4.0  1.9—8.5  4.3  1.5—12.1  4.5  1.6—12.6
Renal  Failure  2.9  1.6—5.4  9.2  2.7—30.6  9.4  2.9—30.0
Other  Infections  2.0  1.2—3.5  21.6  1.9—243.9  —  —
a Adjusted for age- and gender, as well as primary diagnosis for admission, type of admission unit (medical-surgical or critical
care), and admission month.
b Adjusted for all other independent variables in the model, as well as for matching factors.
c Pseudo R2 for models 2 and 3 was .40 and .33 respectively.
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aboratory-conﬁrmed  cases,  did  not  report  the  mor-
ality rate.  Therefore,  we  were  unable  to  compare
ur ﬁndings  with  other  ﬁndings  from  larger  clinical
tudies  in  the  USA  or  Europe.
This study  showed  that  the  most  prevalent  spe-
iﬁc causative  agent  noted  in  the  cultures  was
. aureus  (25.8%).  This  result  was  consistent  with
esults from  a  large  clinical  study  by  Wisplinghoff
t al.  [13]  who  prospectively  collected  clinical  data
rom 49  hospitals  in  the  USA.  Their  ﬁndings  showed
hat S.  aureus  account  for  approximately  20%
f positive  cultures.  Moreover,  this  study  demon-
trated  that  approximately  37%  of  HCABSI  patients
ave at  least  one  other  type  of  infection.  This  result
s consistent  with  other  studies  that  have  reported
econdary HCABSIs  of  33%  [35]  and  84%  [36].
The ﬁndings  from  this  study  that  were  related
o HCABSI  risk  factors  were  similar  to  the  ﬁndings
rom other  studies  [12,37].  The  results  from  this
tudy demonstrated  that  clinical  factors  present
he greatest  risk  for  acquiring  HCABSIs.  For  exam-
le, the  receipt  of  blood  products  increases  the  risk
f acquiring  HCABSIs  by  approximately  18  times.
hese  results  were  consistent  with  the  ﬁndings  from
ther studies  [38,39].  Moreover,  the  current  study
howed  that  the  risk  of  acquiring  infections  was  4
imes greater  in  the  patients  who  undergo  invasive
rocedures  than  those  who  do  not.  These  results
ere supported  by  other  studies  [14,40].  These
ndings were  expected  because  these  invasive  pro-
edures crossed  the  body’s  barriers  and  resulted
n infection.  Approximately  one-third  of  infected
atients in  this  study  were  patients  with  renal  fail-
re, which  increased  the  risk  for  HCABSIs  by  3
imes. Similar  ﬁndings  have  been  reported  in  vari-
us studies  [41,42].  Renal  failure  increases  the  risk
f HCABSIs  because  of  hemodialysis  and  related
reatments [43]  and  because  of  the  direct  negative
mpact  of  renal  failure  on  immunity  [44].  Similar
o the  results  found  by  Al-Rawajfah  and  colleagues
12], this  study  demonstrated  that  advanced  age
s not  one  of  the  primary  risk  factors  for  HCAB-
Is. This  ﬁnding  supports  the  notation  that  HCABSIs
re more  related  to  clinical  (modiﬁable)  risk  fac-
ors, which  emphasizes  the  role  of  infection  control
easures  and  compliance  to  minimize  the  risk  of
nfection.
The major  limitations  of  this  study  are  the  use
f a  single  (although  large)  hospital  in  Jordan.
his hospital  represents  one  health  care  sector  in
ordan. Many  hospitals  in  Jordan,  particularly  in
he governmental  hospitals,  do  not  keep  electronic
ecords for  their  patients.  Therefore,  the  inclu-
ion  of  hospitals  without  electronic  patient  records
ould be  challenging,  particularly  when  using  the
etrospective  design.  Nonetheless,  the  data  from
ﬂ
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his  study  provide  an  initial  status  report  on  a
igniﬁcant  problem  that  is  shared  by  both  devel-
ped  and  developing  nations.
Because  we  failed  to  match  36.8%  of  the  cases
nd controls  based  on  the  same  admission  unit,
eferral  bias  can  be  considered  to  be  one  limitation
f this  study.  Referral  bias  occurs  when  the  study
dmission  rates  differ  [45].  Dawson  and  Trapp  [45]
uggested including  controls  from  a wide  variety
f disease  categories  to  overcome  this  limitation.
herefore, future  research  should  include  cases  and
ontrols from  different  hospitals  as  well  as  control-
ing for  the  admission  unit.
Another  limitation  of  our  study  was  the  miss-
ng variables.  We  were  unable  to  examine  many
isk factors  that  are  known  to  affect  HCABSIs.
or example,  illness  severity,  malnutrition,  trauma,
nfection control  practices,  and  unit  stafﬁng  are
xamples  of  variables  that  were  not  examined
y this  study.  Developing  a  multicenter  study,
ncluding hospitals  from  different  health  care  sec-
ors in  Jordan,  is  highly  desirable.  Moreover,  a
tudy conducted  with  the  prospective  design  will
xamine variables  that  were  not  examined  in this
tudy.
onclusions
n  summary,  the  basic  approaches  to  fostering
tringent aseptic  techniques  through  educational,
ehavioral, and  environmental  approaches  that
ave been  successful  in  other  countries  are  being
onsidered  (or  tried)  in  Jordan.  We  think  that
he results  from  our  study  can  be  used  to  pos-
tively inﬂuence  the  infection  control  efforts  in
he study  hospital  and  in  other  similar  hospi-
als. In  addition,  we  believe  our  results  can  be
sed to  guide  and  strengthen  educational  curricula
egarding  the  assessment  and  control  of  health  care
cquired  infections.  Indeed,  we  must  convey  the
rgent need  to  control  HCABSIs  and  other  serious
nfections because  they  take  a signiﬁcant  toll  on
he health  and  economic  well-being  of  Jordanian
itizens.
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